Lisa Helen Chamberlin

Title: Innovations of Lisa Helen Chamberlin

Introduction

Lisa Helen Chamberlin is an accomplished inventor based in East Syracuse, NY (US). She holds a total of four patents, showcasing her expertise in the field of detection methods and systems. Her innovative work has significantly contributed to advancements in the detection of harmful substances.

Latest Patents

One of her latest patents is focused on methods and systems for the detection of ricin and other ribosome inactivating proteins. This invention includes a device, method, and system for detecting ribosome inactivating protein activity, including the ricin toxin, in a sample. The process involves the removal of an adenine from a labeled DNA substrate, creating an abasic site that allows for the detection of fluorescence signals, indicating ribosome inactivating protein activity in real time. Another notable patent involves detecting a target molecule in a sample using a dual-antibody quantitative fluorescence-based detection method. This kit and method utilize a first probe with an antibody conjugated to an RNA oligonucleotide and a second probe with an antibody conjugated to a DNA oligonucleotide, enabling precise detection of targets in various samples.

Career Highlights

Throughout her career, Lisa has worked with notable companies such as Src Corporation and Acumen Detection, Inc. Her contributions to these organizations have been instrumental in developing innovative detection technologies.

Collaborations

Lisa has collaborated with talented individuals, including Kenton Arthur Doctor and Stacey Ann Massulik. These partnerships have further enhanced her work and expanded the impact of her inventions.

Conclusion

Lisa Helen Chamberlin's innovative contributions to detection technologies demonstrate her significant role in advancing scientific research and safety. Her patents reflect her dedication to improving methods for identifying harmful substances, making her a notable figure in the field of invention.